Cheol Lee J, Hung JY, Kim YC, Chang GC, Soo Yoo S, Yang SH, Davis KL, Nagar SP, Taylor A, Yong Lee S, Shih JY. Real-world treatment patterns in patients with EGFR mutation-positive NSCLC receiving a first line, first- or second-generation EGFR tyrosine kinase inhibitor in South Korea and Taiwan. Asian Pac J Cancer Bio. 2021 May 20;6(2). doi: 10.31557/APJCB.2021.6.2.123-132
Yande SD, Masurkar PP, Gopinathan S, S Sansgiry S. A naturalistic observation study of medication counseling practices at retail chain pharmacies. Pharm Pract (Granada). 2020 Jan;18(1):1696. doi: 10.18549/PharmPract.2020.1.1696